Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-12 with Paromomycin and Azithromycin for Cryptosporidiosis in AIDS
NCT00057486Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 1997
- Primary completion
- Jun 2005
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of recombinant interleukin-12 in cryptosporidiosis, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 1997; status: terminated.
02
Drugs
recombinant interleukin-12
03
Conditions
cryptosporidiosis
Beyond the preview
Go deeper on NCT00057486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057486.